XML 102 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current Assets:      
Cash $ 38,232 $ 367,321 $ 33,478
Other current assets 68,648 66,950
Total Current Assets 106,880 434,271 33,478
Investments held in the Trust Account 61,551,082 60,765,154
Deferred offering costs   234,428
Total Assets 61,657,962 61,199,425 267,906
Current liabilities:      
Accrued expenses and other payable 682,579 395,506 14,208
Deposit from the target company 330,969 330,969
Total Current Liabilities 1,133,548 816,475 309,208
Derivative warrant liability – private warrant 6,860 8,900
Deferred underwriting commission 2,012,500 2,012,500
Total Liabilities 3,152,908 2,837,875 309,208
COMMITMENTS AND CONTINGENCIES (Note 6)  
Class A ordinary shares subject to possible redemption 61,551,082 58,997,725 58,997,725
Shareholders’ Deficit:      
Preferred shares value
Additional paid-in capital   24,856
Accumulated deficit (3,046,206) (636,353) (66,302)
Total Shareholders’ Deficit (3,046,028) (636,175) (41,302)
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit 61,657,962 61,199,425 267,906
Related Party      
Current liabilities:      
Promissory note – related party   295,000
Due to a related party 120,000 90,000
Class A Ordinary Shares      
Shareholders’ Deficit:      
Ordinary shares value 34 34
Class B Ordinary Shares      
Shareholders’ Deficit:      
Ordinary shares value $ 144 $ 144 [1] $ 144 [1]
[1] As of December 31, 2022, this number includes an aggregate of up to 187,500 shares of Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On March 28, 2023, the over-allotment option was fully exercised.